Bartushak Jaime 4
4 · CITIUS ONCOLOGY, INC. · Filed Aug 14, 2024
Insider Transaction Report
Form 4
Bartushak Jaime
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2024-08-12+466,667→ 466,667 totalExercise: $2.15Exp: 2033-07-05→ Common Stock (466,667 underlying)
Footnotes (1)
- [F1]This option, originally issued by Citius Oncology Sub, Inc., vests over three years, beginning July 5, 2023, with 1/36th every month for the first year, and the 1/3 each on the second and third anniversary of the July 5, 2023, provided that the Reporting Person provides continuous services to Citius Oncology Sub, Inc. or a related entity as of each such vesting date. The option was assumed by Citius Oncology, Inc. in the merger transaction, which closed August 12, 2024.